Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Tripar Multivision Plus Tbk. (RAAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Tripar Multivision Plus Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Tripar Multivision Plus Tbk. trades at Rp202 (market cap 1.38T, 1.56M 24h volume). The key difference: Tripar Multivision Plus Tbk. is far larger — about 8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Tripar Multivision Plus Tbk. is more actively traded (1.56M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | RAAM | |
|---|---|---|
Market Cap | 172.82B | 1.38T |
Volume | 592.2K | 1.56M |
Lot | 5.92K | 15.58K |
Turnover | 147.05M | 314.38M |
Average Price | 248.31 | 201.83 |
Value | 147.05M | 314.38M |
Indicative Equilibrium Price | 254 | 202 |
Indicative Equilibrium Volume | 10 | 16 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Tripar Multivision Plus Tbk.
PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.
Read more on RAAM →
